CAT-8015 Immunotoxin
Sponsors
Cambridge Antibody Technology
Conditions
HCLHairy Cell LeukemiaLeukemiaNHLNon-Hodgkin's Lymphoma
Phase 1
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
NCT00457860
Start: 2007-03-31Target: 50Updated: 2007-04-17
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
NCT00462189
Start: 2007-04-30Target: 40Updated: 2007-04-18
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
NCT00515892
Start: 2007-08-31Target: 50Updated: 2007-08-14